Matthew P. Young Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Matthew P. Young.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Matthew P. Young. Matthew P. Young is a EVP & CFO in Jazz Pharmaceuticals plc ($JAZZ) and a SVP & CFO in Jazz Pharmaceuticals plc ($JAZZ) and a Director in CytomX Therapeutics, Inc. ($CTMX) and a Director in PRA Health Sciences, Inc. ($PRAH).
Address: C/O JAZZ PHARMACEUTICALS PLC CONNAUGHT HOUSE, 1 BURLINGTON RD, FL. 4 DUBLIN 4 Ireland
Companies in which Matthew P. Young is an Insider
CytomX Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Matthew P. Young: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 17 2021
$CTMX Market Capitalization: $410.61M
$CTMX Previous Close: $11.50
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Jazz Pharmaceuticals plc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Matthew P. Young: EVP & CFO, SVP & CFO
Holdings: 38,700 shares
Current Value: $4,839,435
Latest Transaction: Mar 07 2019
$JAZZ Market Capitalization: $7.62B
$JAZZ Previous Close: $125.05
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
PRA Health Sciences, Inc.
Industry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of Matthew P. Young: Director
Holdings: 6,877 shares
Current Value: $401,754
Latest Transaction: May 20 2020
$PRAH Market Capitalization: $3.62B
$PRAH Previous Close: $58.42
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Matthew P. Young
Sentiment: All, CTMX, JAZZ, PRAH
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 17 2021 | CTMX | CytomX Therapeutic ... | Young Matthew P. | Director | Option Exercise | A | 7.13 | 20,000 | 142,600 | 20,000 | |
| Jun 17 2020 | CTMX | CytomX Therapeutic ... | Young Matthew P. | Director | Option Exercise | A | 8.35 | 20,000 | 167,000 | 20,000 | |
| May 20 2020 | PRAH | PRA Health Science ... | Young Matthew P. | Director | Grant | A | 0.00 | 1,324 | 0 | 6,877 | 5.6 K to 6.9 K (+23.84 %) |
| Jun 21 2019 | CTMX | CytomX Therapeutic ... | Young Matthew P. | Director | Option Exercise | A | 11.31 | 14,000 | 158,340 | 14,000 | |
| Jun 05 2019 | PRAH | PRA Health Science ... | Young Matthew P. | Director | Grant | A | 0.00 | 1,436 | 0 | 5,553 | 4.1 K to 5.6 K (+34.88 %) |
| Mar 07 2019 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Sell | S | 135.41 | 1,152 | 155,992 | 36,200 | 37.4 K to 36.2 K (-3.08 %) |
| Mar 07 2019 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Payment of Exercise | F | 135.82 | 1,348 | 183,085 | 37,352 | 38.7 K to 37.4 K (-3.48 %) |